litlas
ログインアカウント作成

Michaëla Diamant

1993–2020 年に発表

74
論文数
24,262
被引用数
72
h 指数
74
i10 指数

被引用数

Michaëla Diamant の年別被引用数1994 年: 被引用 3 件1995 年: 被引用 8 件1996 年: 被引用 4 件1997 年: 被引用 3 件1998 年: 被引用 5 件1999 年: 被引用 6 件2000 年: 被引用 7 件2001 年: 被引用 10 件2002 年: 被引用 6 件2003 年: 被引用 10 件2004 年: 被引用 27 件2005 年: 被引用 30 件2006 年: 被引用 41 件2007 年: 被引用 67 件2008 年: 被引用 94 件2009 年: 被引用 95 件2010 年: 被引用 163 件2011 年: 被引用 166 件2012 年: 被引用 254 件2013 年: 被引用 396 件2014 年: 被引用 457 件2015 年: 被引用 399 件2016 年: 被引用 352 件2017 年: 被引用 363 件2018 年: 被引用 294 件2019 年: 被引用 843 件2020 年: 被引用 663 件2021 年: 被引用 572 件2022 年: 被引用 375 件2023 年: 被引用 247 件2024 年: 被引用 354 件2025 年: 被引用 206 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,817 件、この内訳の 20.9%イギリス: 引用元論文 763 件、この内訳の 8.8%中国: 引用元論文 589 件、この内訳の 6.8%ドイツ: 引用元論文 473 件、この内訳の 5.5%オランダ: 引用元論文 436 件、この内訳の 5%イタリア: 引用元論文 432 件、この内訳の 5%カナダ: 引用元論文 320 件、この内訳の 3.7%オーストラリア: 引用元論文 266 件、この内訳の 3.1%フランス: 引用元論文 264 件、この内訳の 3%デンマーク: 引用元論文 249 件、この内訳の 2.9%日本: 引用元論文 220 件、この内訳の 2.5%スウェーデン: 引用元論文 198 件、この内訳の 2.3%
0%20.9%その他 30.5%

機関

分野

  • Medicine79.2%
  • Biochemistry, Genetics and Molecular Biology11.7%
  • Neuroscience2.6%
  • Psychology2.1%
  • Health Professions0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • その他3%

トピック

  • Diabetes Treatment and Management11.4%
  • Diabetes Management and Research6.2%
  • Pancreatic function and diabetes4.9%
  • Metabolism, Diabetes, and Cancer4.4%
  • Cardiovascular Function and Risk Factors4.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.6%
  • その他65.1%

共著者

全論文

検索で開く
  1. GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans

    著者: Liselotte van Bloemendaal, Richard G. IJzerman, Jennifer S. ten Kulve, Frederik Barkhof, Robert J. Konrad, Madeleine L. Drent, Dick J. Veltman, Michaëla Diamant - Diabetes 2014 被引用: 411

  2. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    著者: Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, Ele Ferrannini, Michael A. Nauck, Anne L. Peters, Απόστολος Τσάπας, Richard C. Wender, David R. Matthews - Diabetes Care 2014 被引用: 3,078

  3. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

    著者: Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, Ele Ferrannini, Michael A. Nauck, Anne L. Peters, Απόστολος Τσάπας, Richard C. Wender, David R. Matthews - Diabetes Care 2012 被引用: 3,218

  4. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial

    著者: C.A.J. van Beers, J. Hans DeVries, Susanne J. Kleijer, Mark M. Smits, Petronella Geelhoed-Duijvestijn, Mark H.H. Kramer, Michaëla Diamant, Frank J. Snoek, Erik H. Serné - The Lancet Diabetes & Endocrinology 2016 被引用: 383

  5. Diastolic Stiffness of the Failing Diabetic Heart

    著者: Loek van Heerebeek, Nazha Hamdani, M. Louis Handoko, Inês Falcão‐Pires, René J.P. Musters, Koba Kupreishvili, Alexander Ijsselmuiden, Casper G. Schalkwijk, Jean G.F. Bronzwaer, Michaëla Diamant, Attila Borbély, Jolanda van der Velden, Ger J.M. Stienen, Gerrit J. Laarman, Hans W.M. Niessen, Walter J. Paulus - Circulation 2007 被引用: 731

  6. Altered Myocardial Substrate Metabolism and Decreased Diastolic Function in Nonischemic Human Diabetic Cardiomyopathy

    著者: Luuk J. Rijzewijk, R.W. van der Meer, Hildo J. Lamb, Hugo W. A. M. de Jong, Mark Lubberink, Johannes A. Romijn, Jeroen J. Bax, Albert de Roos, Jos W. R. Twisk, Robert J. Heine, Adriaan A. Lammertsma, Johannes W. A. Smit, Michaëla Diamant - Journal of the American College of Cardiology 2009 被引用: 308

  7. Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial

    著者: Mark M. Smits, Lennart Tonneijck, Marcel H.A. Muskiet, Mark H.H. Kramer, Petra J. W. Pouwels, Indra C. Pieters-van den Bos, Trynke Hoekstra, Michaëla Diamant, Daniël H. van Raalte, Djuna L. Cahen - Diabetologia 2016 被引用: 140

  8. Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus

    著者: Luuk J. Rijzewijk, R.W. van der Meer, Johannes W. A. Smit, Michaëla Diamant, Jeroen J. Bax, Sebastiaan Hammer, Johannes A. Romijn, Albert de Roos, Hildo J. Lamb - Journal of the American College of Cardiology 2008 被引用: 552

  9. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

    著者: Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A.H. Jan Danser, Michaëla Diamant, Jaap A. Joles, Daniël H. van Raalte - Diabetologia 2016 被引用: 128

  10. Endothelial Glycocalyx Damage Coincides With Microalbuminuria in Type 1 Diabetes

    著者: Max Nieuwdorp, Hans L. Mooij, Jojanneke Kroon, Bektaş Atasever, Jos A. E. Spaan, Can İnce, F. Holleman, Michaëla Diamant, Robert J. Heine, J. B. L. Hoekstra, John J.P. Kastelein, Erik S.G. Stroes, Hans Vink - Diabetes 2006 被引用: 434

  11. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    著者: Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, Ele Ferrannini, Michael A. Nauck, Anne L. Peters, Απόστολος Τσάπας, Richard C. Wender, David R. Matthews - Diabetologia 2015 被引用: 690

  12. Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

    著者: Michaëla Diamant, Luc Van Gaal, Stephen Stranks, Justin Northrup, Dachuang Cao, Kristin Taylor, Michael Trautmann - The Lancet 2010 被引用: 436

  13. Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes

    著者: Maarten E. Tushuizen, Mathijs C. Bunck, Petra J. W. Pouwels, Saskia Bontemps, Jan Hein T. van Waesberghe, Roger K. Schindhelm, Andrea Mari, Robert J. Heine, Michaëla Diamant - Diabetes Care 2007 被引用: 394

  14. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    著者: S. E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, E. Ferrannini, M. Nauck, Anne L. Peters, Απόστολος Τσάπας, R. Wender, David R. Matthews - Diabetologia 2012 被引用: 3,932

  15. Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

    著者: Mathijs C. Bunck, Michaëla Diamant, Björn Eliasson, A. H. Corner, Rimma M. Shaginian, Robert J. Heine, Marja‐Riitta Taskinen, Hannele Yki‐Järvinen, Ulf Smith - Diabetes Care 2010 被引用: 156

  16. The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?

    著者: Marcel H.A. Muskiet, Mark M. Smits, Linde M. Morsink, Michaëla Diamant - Nature Reviews Nephrology 2013 被引用: 177

  17. Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing

    著者: Mark Fineman, Shawn Flanagan, Kristin Taylor, Maria Aisporna, Larry Z. Shen, Kenneth Mace, Brandon Walsh, Michaëla Diamant, Brenda Cirincione, Prajakti A. Kothare, Wen-I Li, Leigh MacConell - Clinical Pharmacokinetics 2010 被引用: 135

  18. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

    著者: Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A.H. Jan Danser, Piet M. ter Wee, Michaëla Diamant, Jaap A. Joles, Daniël H. van Raalte - Diabetes Care 2016 被引用: 114

  19. Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner

    著者: Marc C. Huisman, Larissa W. van Golen, Nikie J. Hoetjes, Henri N. Greuter, Patrick Schober, Richard G. IJzerman, Michaëla Diamant, Adriaan A. Lammertsma - EJNMMI Research 2012 被引用: 83

  20. One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients

    著者: Mathijs C. Bunck, Michaëla Diamant, A. H. Corner, Björn Eliasson, Jaret Malloy, Rimma M. Shaginian, Wei Deng, David M. Kendall, Marja‐Riitta Taskinen, Ulf Smith, Hannele Yki‐Järvinen, Robert J. Heine - Diabetes Care 2009 被引用: 387

  21. Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus

    著者: R.W. van der Meer, Luuk J. Rijzewijk, Hugo W. A. M. de Jong, Hildo J. Lamb, Mark Lubberink, Johannes A. Romijn, Jeroen J. Bax, Albert de Roos, Otto Kamp, Walter J. Paulus, Robert J. Heine, Adriaan A. Lammertsma, Johannes W. A. Smit, Michaëla Diamant - Circulation 2009 被引用: 238

  22. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes

    著者: Jennifer S. ten Kulve, Dick J. Veltman, Liselotte van Bloemendaal, Frederik Barkhof, Carolyn F. Deacon, Jens J. Holst, Robert J. Konrad, John H. Sloan, Madeleine L. Drent, Michaëla Diamant, Richard G. IJzerman - Diabetologia 2015 被引用: 108

  23. Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes

    著者: Jennifer S. ten Kulve, Dick J. Veltman, Liselotte van Bloemendaal, Frederik Barkhof, Madeleine L. Drent, Michaëla Diamant, Richard G. IJzerman - Diabetes Care 2015 被引用: 94

  24. Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease

    著者: Roger K. Schindhelm, Michaëla Diamant, Joost Dekker, Maarten E. Tushuizen, Tom Teerlink, Robert J. Heine - Diabetes/Metabolism Research and Reviews 2006 被引用: 378